0001628280-21-011906.txt : 20210609 0001628280-21-011906.hdr.sgml : 20210609 20210609213819 ACCESSION NUMBER: 0001628280-21-011906 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210609 FILED AS OF DATE: 20210609 DATE AS OF CHANGE: 20210609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NAZEM FARZAD CENTRAL INDEX KEY: 0001234663 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 211006706 MAIL ADDRESS: STREET 1: C/O YAHOO INC STREET 2: 701 FIRST AVE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 3 1 wf-form3_162328908574846.xml FORM 3 X0206 3 2021-06-09 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001234663 NAZEM FARZAD C/O NAUTILUS BIOTECHNOLOGY, INC. 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 1 0 0 0 Common Stock 1888146 I By HAND Capital, LLC Stock Option (Right to Buy) 10.0 2031-01-31 Common Stock 36280.0 D Shares held by HAND Capital, LLC. The reporting person is the manager of HAND Capital, LLC. Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through the applicable vesting date, one hundred percent (100%) of the shares subject to the Option shall vest on the earlier of (a) the one (1) year anniversary of the Vesting Commencement Date (as defined below) and (b) the day immediately before the date of the next annual meeting of stockholders of the Company (or in the event of a merger or consolidation involving the Company in which the Company is a wholly-owned subsidiary immediately following such merger or consolidation, the next annual meeting of stockholders of the Company's parent). The Vesting Commencement Date is January 31, 2021. Exhibit 24: Power of Attorney /s/ Anna Mowry, as Attorney-in-Fact 2021-06-09 EX-24 2 ex-24.htm FARZAD NAZEM - POA

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Nautilus Biotechnology, Inc. (the "Company"), hereby constitutes and appoints Sujal Patel, Anna Mowry, Matt Murphy, Zachary Myers, Robert F. Kornegay, and Ben Capps the undersigned's true and lawful attorneys-in-fact to:

1.    complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorneys-in-fact shall in their discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned's ownership, acquisition or disposition of securities of the Company; and

2.    do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys in-fact and agent shall do or cause to be done by virtue hereof.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of June, 2021.



Signature:   /s/ Farzad Nazem

Print Name:   Farzad Nazem